{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:53Z","timestamp":1760267753365,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To verify the level of adherence to the influenza vaccination program in a population of patients suffering from RA, PsA or AS undergoing immunosuppressive treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Administrative databases from the Regional Health Information System of Friuli Venezia Giulia (FVG), Italy, were used. Subjects were residents in FVG, suffered from chronic inflammatory arthritis and had at least one prescription for a DMARD in the 9\u2009months before the start of the vaccination season (from 1 October to 31 December). The observation ranged from 2006 to 2018. Logistic regression was used to assess the association between vaccination and the patient\u2019s characteristics in the 2018\u20132019 influenza season.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, vaccination adherence decreased from the highest value of 35.7% (662\/1853) in 2006 to the lowest value of 25.3% (926\/3663) in 2014; in people \u226565\u2009years of age it also decreased over time from 61.6% (577\/936) in 2008 to 43.9% (701\/1595) in the 2014. By logistic analysis on the 2018\u20132019 season, which included 4460 patients, older subjects were more likely to be vaccinated [people 65\u201374\u2009years, odds ratio (OR) 4.58 (95% CI 3.72, 5.64); people 75\u201384\u2009years, OR 6.47 (95% CI 5.04, 8.32); both vs &amp;lt;65] as were those with diabetes [OR 1.66 (95% CI 1.05, 2.64)]. Treatment with a biologic agent alone [OR 0.64 (95% CI 0.52, 0.80)] and RA diagnosis [OR 0.69 (95% CI 0.51, 0.93)] were associated with lower adherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Influenza vaccination adherence is alarmingly low in a population at higher risk of infectious complications, in particular in elderly patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa454","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:08:53Z","timestamp":1593688133000},"page":"2456-2460","source":"Crossref","is-referenced-by-count":2,"title":["Influenza vaccination in chronic inflammatory arthritis undergoing immunosuppressive treatments: temporal trend and factors of adherence"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-6439","authenticated-orcid":false,"given":"Luca","family":"Quartuccio","sequence":"first","affiliation":[{"name":"Clinic of Rheumatology, Department of Medicine, Academic Hospital \u201cSanta Maria della Misericordia\u201d, Azienda sanitaria universitaria Friuli Centrale, University of Udine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-464X","authenticated-orcid":false,"given":"Alen","family":"Zabotti","sequence":"additional","affiliation":[{"name":"Clinic of Rheumatology, Department of Medicine, Academic Hospital \u201cSanta Maria della Misericordia\u201d, Azienda sanitaria universitaria Friuli Centrale, University of Udine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolinda","family":"Gallo","sequence":"additional","affiliation":[{"name":"Department of Prevention, Azienda sanitaria universitaria Friuli Centrale"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[{"name":"Clinic of Rheumatology, Department of Medicine, Academic Hospital \u201cSanta Maria della Misericordia\u201d, Azienda sanitaria universitaria Friuli Centrale, University of Udine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Valent","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology, Academic Hospital \u201cSanta Maria della Misericordia\u201d, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"2021051418595857600_keaa454-B1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","article-title":"Broadly protective strategies against influenza viruses: universal vaccines and therapeutics","volume":"11","author":"Vogel","year":"2020","journal-title":"Front Microbiol"},{"key":"2021051418595857600_keaa454-B2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021051418595857600_keaa454-B3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa078","article-title":"Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs","author":"Nakafero","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2021051418595857600_keaa454-B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jare.2018.09.003","article-title":"Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data","volume":"15","author":"Quartuccio","year":"2018","journal-title":"J Adv Res"},{"key":"2021051418595857600_keaa454-B5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/key156","article-title":"Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study","volume":"57","author":"Nakafero","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2021051418595857600_keaa454-B6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"Nguyen","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2021051418595857600_keaa454-B7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3899\/jrheum.181376","article-title":"Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care","volume":"47","author":"Qendro","year":"2020","journal-title":"J Rheumatol"},{"key":"2021051418595857600_keaa454-B8","doi-asserted-by":"crossref","first-page":"e000198","DOI":"10.1136\/fmch-2019-000198","article-title":"Glycaemic control, antidiabetic medications and influenza vaccination coverage among patients with diabetes in Udine, Italy","volume":"7","author":"Valent","year":"2019","journal-title":"Fam Med Community Health"},{"year":"2020","key":"2021051418595857600_keaa454-B9"},{"key":"2021051418595857600_keaa454-B10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Charlotte","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021051418595857600_keaa454-B11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajic.2010.04.210","article-title":"Awareness of government seasonal and 2009 H1N1 influenza vaccination recommendations among targeted US adults: the role of provider interactions","volume":"38","author":"Maurer","year":"2010","journal-title":"Am J Infect Control"},{"key":"2021051418595857600_keaa454-B12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/341403","article-title":"Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations","volume":"35","author":"Hak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2021051418595857600_keaa454-B13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2015.01.002","article-title":"Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus","volume":"44","author":"Lawson","year":"2015","journal-title":"Semin Arthritis Rheum"},{"volume-title":"Stima dell\u2019efficacia di campo del vaccino antinfluenzale, in Italia: stagioni 2010\u20132011 e 2011\u20132012","year":"2016","author":"Rizzo","key":"2021051418595857600_keaa454-B14"},{"year":"2017","author":"Spila Alegiani","key":"2021051418595857600_keaa454-B15"},{"key":"2021051418595857600_keaa454-B16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1871528114666160105113046","article-title":"Vaccination and induction of autoimmune diseases","volume":"14","author":"Toussirot","year":"2016","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2021051418595857600_keaa454-B17","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"key":"2021051418595857600_keaa454-B18","doi-asserted-by":"crossref","first-page":"e0153848","DOI":"10.1371\/journal.pone.0153848","article-title":"Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink","volume":"11","author":"Costello","year":"2016","journal-title":"PLoS One"},{"key":"2021051418595857600_keaa454-B19","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/ard.2011.152983","article-title":"Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice","volume":"70","author":"Ribeiro","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021051418595857600_keaa454-B20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Oxford"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2456\/37935870\/keaa454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2456\/37935870\/keaa454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T19:00:51Z","timestamp":1621018851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/5\/2456\/5934066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,10,21]]},"published-print":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa454","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,10,21]]}}}